$INTI
Market Cap:
$11.37 Million
Financial Snapshot
Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$3.085M
TTM
Current Ratio
14478.43%
Q3 2024
Book Value
$3.407M
Q3 2024
P/E
-3.687
Nov 26, 2024 EST
Free Cash Flow
Revenues
Revenues
Loading...
Loading...
Revenue YoY Change
Loading...
Loading...
Revenues
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $100.0K | $3.720M | $9.030M | $6.530M | $7.800M | $5.750M | $5.100M | $4.430M | $4.790M | $4.370M | $2.570M | $1.600M | $1.760M | $990.0K | $370.0K | ||
| YoY Change | -100.0% | -97.31% | -58.8% | 38.28% | -16.28% | 35.65% | 12.75% | 15.12% | -7.52% | 9.61% | 70.04% | 60.63% | -9.09% | 77.78% | 167.57% |
Expenses
Cost Of Revenues
Loading...
Loading...
Gross Profit
Loading...
Loading...
Gross Profit Margin
Loading...
Loading...
Gross Profit
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $100.0K | $3.720M | $9.030M | $6.530M | $7.800M | $5.750M | $5.100M | $4.430M | $4.790M | $4.370M | $2.570M | $1.600M | $1.760M | $990.0K | $370.0K | ||
| Cost Of Revenue | $2.860M | $7.450M | $5.440M | $5.560M | $3.770M | $3.530M | $3.370M | $4.100M | $3.180M | $2.060M | $1.600M | $1.370M | $550.0K | $150.0K | |||||||||||||||
| Gross Profit | $860.0K | $1.580M | $1.090M | $2.240M | $1.980M | $1.570M | $1.060M | $690.0K | $1.190M | $510.0K | $0.00 | $390.0K | $440.0K | $220.0K | |||||||||||||||
| Gross Profit Margin | 23.12% | 17.5% | 16.69% | 28.72% | 34.43% | 30.78% | 23.93% | 14.41% | 27.23% | 19.84% | 0.0% | 22.16% | 44.44% | 59.46% |
Selling, General & Admin Expense
Loading...
Loading...
Research & Development
Loading...
Loading...
Depreciation, Depletion & Amortization
Loading...
Loading...
SGA Expense to Gross Profit Ratio
Loading...
Loading...
R&D To Gross Profit Ratio
Loading...
Loading...
DDA To Gross Profit Ratio
Loading...
Loading...
Operating Expenses Total
Loading...
Loading...
Operating Profits/Loss
Loading...
Loading...
Operational Expenses
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General & Admin | $2.024M | $651.8K | $320.5K | $873.7K | $1.540M | $1.931M | $2.891M | $4.381M | $2.269M | $1.507M | $820.0K | $560.0K | $980.0K | $1.030M | $1.890M | $4.290M | $4.140M | $2.050M | $1.990M | $1.720M | $1.420M | $1.400M | $2.020M | $1.820M | $2.370M | $2.250M | $1.300M | $320.0K | $220.0K |
| YoY Change | 210.52% | 103.37% | -63.32% | -43.26% | -20.25% | -33.23% | -34.0% | 93.04% | 50.58% | 83.79% | 46.43% | -42.86% | -4.85% | -45.5% | -55.94% | 3.62% | 101.95% | 3.02% | 15.7% | 21.13% | 1.43% | -30.69% | 10.99% | -23.21% | 5.33% | 73.08% | 306.25% | 45.45% | |
| % of Gross Profit | 498.84% | 262.03% | 188.07% | 88.84% | 86.87% | 90.45% | 132.08% | 292.75% | 152.94% | 464.71% | 333.33% | 72.73% | 100.0% | ||||||||||||||||
| Research & Development | $1.381M | $6.150K | $4.910K | $185.3K | $1.208M | $2.634M | $2.228M | $2.642M | $1.680M | $2.431M | $1.065M | ||||||||||||||||||
| YoY Change | 22356.42% | 25.25% | -97.35% | -84.66% | -54.13% | 18.22% | -15.67% | 57.21% | -30.87% | 128.2% | |||||||||||||||||||
| % of Gross Profit | |||||||||||||||||||||||||||||
| Depreciation & Amortization | $0.00 | $0.00 | $160.0K | $180.0K | $1.040M | $2.740M | $890.0K | $900.0K | $960.0K | $790.0K | $610.0K | $630.0K | $670.0K | $640.0K | $550.0K | $320.0K | $280.0K | $50.00K | $40.00K | ||||||||||
| YoY Change | -100.0% | -11.11% | -82.69% | -62.04% | 207.87% | -1.11% | -6.25% | 21.52% | 29.51% | -3.17% | -5.97% | 4.69% | 16.36% | 71.88% | 14.29% | 460.0% | 25.0% | ||||||||||||
| % of Gross Profit | 318.6% | 56.33% | 82.57% | 42.86% | 39.9% | 38.85% | 59.43% | 97.1% | 53.78% | 107.84% | 71.79% | 11.36% | 18.18% | ||||||||||||||||
| Operating Expenses | $3.405M | $657.9K | $325.4K | $1.059M | $2.748M | $4.564M | $5.119M | $7.022M | $3.950M | $3.938M | $2.000M | $560.7K | $980.0K | $1.030M | $1.890M | $4.280M | $4.140M | $2.050M | $1.990M | $1.720M | $1.420M | $1.410M | $2.010M | $1.820M | $2.370M | $2.250M | $1.300M | $320.0K | $220.0K |
| YoY Change | 417.53% | 102.19% | -69.27% | -61.46% | -39.8% | -10.84% | -27.1% | 77.8% | 0.3% | 96.91% | 256.68% | -42.79% | -4.85% | -45.5% | -55.84% | 3.38% | 101.95% | 3.02% | 15.7% | 21.13% | 0.71% | -29.85% | 10.44% | -23.21% | 5.33% | 73.08% | 306.25% | 45.45% | |
| Operating Profit | -$3.405M | -$657.9K | -$325.4K | -$1.059M | -$2.748M | -$4.564M | -$5.119M | -$7.022M | -$3.950M | -$3.938M | -$2.000M | -$560.7K | -$3.420M | -$2.560M | -$960.0K | $250.0K | $260.0K | $150.0K | -$350.0K | -$1.320M | -$630.0K | -$1.860M | -$2.250M | -$910.0K | $120.0K | $0.00 | |||
| YoY Change | 417.53% | 102.19% | -69.27% | -61.46% | -39.8% | -10.84% | -27.1% | 77.8% | 0.3% | 96.91% | 256.68% | 33.59% | 166.67% | -484.0% | -3.85% | 73.33% | -142.86% | -73.48% | 109.52% | -66.13% | -17.33% | 147.25% | -858.33% |
Interest Expenses
Loading...
Loading...
Interest Expenses To Operating Income %
Loading...
Loading...
Other Expense/Income
Loading...
Loading...
Interest & Other Expense/Income
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Expense | $378.8K | $23.23K | -$14.84K | $1.070K | $14.54K | $14.03K | $17.87K | $21.99K | $0.00 | $37.48K | $1.923K | $80.00K | -$220.0K | -$230.0K | -$470.0K | -$1.250M | -$500.0K | -$300.0K | -$240.0K | -$650.0K | -$260.0K | -$290.0K | -$190.0K | -$290.0K | -$230.0K | $140.0K | -$260.0K | -$10.00K | -$10.00K |
| YoY Change | 1530.54% | -256.56% | -1486.92% | -92.64% | 3.64% | -21.49% | -18.74% | -100.0% | 1849.09% | -97.6% | -136.36% | -4.35% | -51.06% | -62.4% | 150.0% | 66.67% | 25.0% | -63.08% | 150.0% | -10.34% | 52.63% | -34.48% | 26.09% | -264.29% | -153.85% | 2500.0% | 0.0% | ||
| % of Operating Profit | -96.0% | -250.0% | -173.33% | -8.33% | |||||||||||||||||||||||||
| Other Income/Expense, Net | $0.00 | $1.360M | $610.0K | -$200.0K | -$70.00K | $80.00K | $110.0K | $70.00K | $20.00K | $20.00K | $0.00 | -$110.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||
| YoY Change | -100.0% | 122.95% | -405.0% | 185.71% | -187.5% | -27.27% | 57.14% | 250.0% | 0.0% | -100.0% |
Income/Loss
Pretax Income
Loading...
Loading...
Income Tax
Loading...
Loading...
Net Profits/Loss
Loading...
Loading...
Pretax Income YoY Change
Loading...
Loading...
Income Tax Rate
Loading...
Loading...
Net Profits/Loss YoY Change
Loading...
Loading...
Basic EPS
Loading...
Loading...
Net Income To Revenue Ratio
Loading...
Loading...
Pretax & Net Income
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pretax Income | -$3.026M | $12.16M | -$298.6K | -$1.058M | -$2.733M | -$4.550M | -$5.101M | -$7.000M | -$3.950M | -$3.975M | -$1.840M | $190.0K | -$260.0K | -$640.0K | -$2.460M | -$9.110M | -$2.980M | -$1.150M | $80.00K | -$370.0K | -$80.00K | -$630.0K | -$1.670M | -$920.0K | -$2.090M | -$2.100M | -$1.170M | $110.0K | -$10.00K |
| YoY Change | -124.88% | -4172.38% | -71.77% | -61.3% | -39.93% | -10.8% | -27.13% | 77.24% | -0.65% | 116.05% | -1068.42% | -173.08% | -59.38% | -73.98% | -73.0% | 205.7% | 159.13% | -1537.5% | -121.62% | 362.5% | -87.3% | -62.28% | 81.52% | -55.98% | -0.48% | 79.49% | -1163.64% | -1200.0% | |
| Income Tax | $0.00 | $55.11K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $20.00K | ||
| % Of Pretax Income | 0.45% | 0.0% | 0.0% | ||||||||||||||||||||||||||
| Net Earnings | -$3.026M | $12.11M | -$298.6K | -$1.058M | -$2.733M | -$4.550M | -$5.101M | -$7.000M | -$3.950M | -$3.975M | -$1.835M | $186.4K | -$230.0K | -$1.000M | -$2.360M | -$9.860M | -$2.760M | -$1.150M | $80.00K | -$370.0K | -$80.00K | -$630.0K | -$1.670M | -$920.0K | -$2.090M | -$2.100M | -$1.170M | $110.0K | -$40.00K |
| YoY Change | -125.0% | -4153.92% | -71.77% | -61.3% | -39.93% | -10.8% | -27.13% | 77.24% | -0.65% | 116.63% | -1084.65% | -181.03% | -77.0% | -57.63% | -76.06% | 257.25% | 140.0% | -1537.5% | -121.62% | 362.5% | -87.3% | -62.28% | 81.52% | -55.98% | -0.48% | 79.49% | -1163.64% | -375.0% | |
| Net Earnings / Revenue | -2360.0% | -265.05% | -30.56% | -17.61% | 1.03% | -6.43% | -1.57% | -14.22% | -34.86% | -21.05% | -81.32% | -131.25% | -66.48% | 11.11% | -10.81% | ||||||||||||||
| Basic Earnings Per Share | -$0.02 | $0.03 | $0.00 | -$0.10 | $0.01 | ||||||||||||||||||||||||
| Diluted Earnings Per Share | -$0.02 | $0.03 | -$793.70 | -$2.844K | -$7.379K | -$12.30K | -$13.91K | -$24.24K | -$16.98K | -$41.46K | -$0.10 | $0.01 | -$0.02 | -$0.10 | -$0.33 | -$1.68 | -$0.53 | -$0.35 | $0.02 | -$0.12 | -$0.03 | -$0.29 | -$0.81 | -$0.51 | -$1.27 | -$1.29 | -$0.72 | $0.22 | -$0.07 |
Assets & Liabilities
Cash & Short-Term Investments
Loading...
Loading...
Cash & Equivalents
Loading...
Loading...
Cash To Operating Expenses Ratio
Loading...
Loading...
Inventory
Loading...
Loading...
Receivables
Loading...
Loading...
Total Short-Term Assets
Loading...
Loading...
Property, Plant And Equipment
Loading...
Loading...
Long-Term Investments
Loading...
Loading...
Total Long-Term Assets
Loading...
Loading...
Total Assets
Loading...
Loading...
Net Income To Total Assets Percentage
Loading...
Loading...
Accounts Payable
Loading...
Loading...
Short-Term Debt
Loading...
Loading...
Long Term Debt Due
Loading...
Loading...
Total Short-Term Liabilities
Loading...
Loading...
Long-Term Debt
Loading...
Loading...
Other Long-Term Liabilities
Loading...
Loading...
Total Long-Term Liabilities
Loading...
Loading...
Total Liabilities
Loading...
Loading...
Short-Term To Long-Term Debt Ratio
Loading...
Loading...
Short-Term Assets To Debt Ratio
Loading...
Loading...
Long-Term Debt To Net Income Ratio
Loading...
Loading...
Assets & Liabilities
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Short-Term Investments | $8.840M | $11.95M | $30.63K | $75.06K | $803.8K | $1.109M | $344.1K | $6.885M | $601.5K | $365.2K | $0.00 | $860.0K | $1.320M | $100.0K | $690.0K | $310.0K | $2.530M | $1.900M | $2.810M | $2.740M | $300.0K | $270.0K | $120.0K | $1.580M | $30.00K | $2.090M | $6.270M | $260.0K | $0.00 |
| YoY Change | -26.03% | 38918.02% | -59.19% | -90.66% | -27.5% | 222.2% | -95.0% | 1044.8% | 64.71% | -100.0% | -34.85% | 1220.0% | -85.51% | 122.58% | -87.75% | 33.16% | -32.38% | 2.55% | 813.33% | 11.11% | 125.0% | -92.41% | 5166.67% | -98.56% | -66.67% | 2311.54% | |||
| Cash & Equivalents | $8.840M | $11.95M | $30.63K | $75.06K | $803.8K | $1.109M | $344.1K | $6.885M | $601.5K | $365.2K | $0.00 | $860.0K | $1.320M | $100.0K | $690.0K | $240.0K | $2.530M | $1.900M | $2.810M | $2.740M | $300.0K | $270.0K | $120.0K | $590.0K | $30.00K | $2.090M | $6.270M | $260.0K | $0.00 |
| Short-Term Investments | $0.00 | $0.00 | $0.00 | $0.00 | $70.00K | $0.00 | $0.00 | $1.000M | |||||||||||||||||||||
| Other Short-Term Assets | $109.2K | $23.90K | $28.16K | $32.29K | $42.45K | $41.30K | $311.7K | $311.1K | $34.41K | $97.82K | $10.00K | $80.00K | $50.00K | $2.270M | $0.00 | $90.00K | $650.0K | $430.0K | $120.0K | $70.00K | $60.00K | $80.00K | $70.00K | $100.0K | $70.00K | $80.00K | $60.00K | $0.00 | $0.00 |
| YoY Change | 357.07% | -15.13% | -12.79% | -23.93% | 2.78% | -86.75% | 0.18% | 804.1% | -64.82% | 878.2% | -87.5% | 60.0% | -97.8% | -100.0% | -86.15% | 51.16% | 258.33% | 71.43% | 16.67% | -25.0% | 14.29% | -30.0% | 42.86% | -12.5% | 33.33% | ||||
| Inventory | $0.00 | $2.170M | $40.00K | $10.00K | $0.00 | $0.00 | |||||||||||||||||||||||
| Prepaid Expenses | |||||||||||||||||||||||||||||
| Receivables | $0.00 | $0.00 | $0.00 | $630.0K | $1.450M | $2.900M | $960.0K | $1.340M | $1.330M | $800.0K | $490.0K | $630.0K | $790.0K | $460.0K | $300.0K | $150.0K | $120.0K | $80.00K | |||||||||||
| Other Receivables | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Total Short-Term Assets | $8.949M | $11.98M | $58.78K | $107.4K | $846.3K | $1.150M | $655.8K | $7.197M | $635.9K | $463.0K | $10.00K | $940.0K | $1.380M | $2.370M | $1.330M | $1.850M | $8.240M | $3.300M | $4.280M | $4.140M | $1.160M | $840.0K | $820.0K | $2.470M | $560.0K | $2.470M | $6.490M | $380.0K | $80.00K |
| YoY Change | -25.27% | 20272.78% | -45.24% | -87.31% | -26.41% | 75.37% | -90.89% | 1031.78% | 37.34% | 4529.8% | -98.94% | -31.88% | -41.77% | 78.2% | -28.11% | -77.55% | 149.7% | -22.9% | 3.38% | 256.9% | 38.1% | 2.44% | -66.8% | 341.07% | -77.33% | -61.94% | 1607.89% | 375.0% | |
| Property, Plant & Equipment | $0.00 | $0.00 | $10.00K | $5.660M | $6.360M | $7.520M | $5.610M | $5.970M | $5.700M | $5.650M | $6.200M | $6.790M | $7.160M | $7.020M | $7.260M | $1.440M | $240.0K | $100.0K | |||||||||||
| YoY Change | -100.0% | -99.82% | -11.01% | -15.43% | 34.05% | -6.03% | 4.74% | 0.88% | -8.87% | -8.69% | -5.17% | 1.99% | -3.31% | 404.17% | 500.0% | 140.0% | |||||||||||||
| Goodwill | |||||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||||
| Intangibles | |||||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||||
| Long-Term Investments | |||||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||||
| Other Assets | $0.00 | $24.41K | $53.70K | $82.99K | $112.3K | $141.6K | $250.0K | $0.00 | $0.00 | $3.770M | $300.0K | $170.0K | $1.040M | $70.00K | $90.00K | $110.0K | $780.0K | $790.0K | $740.0K | $720.0K | $670.0K | $670.0K | $10.00K | $10.00K | $0.00 | ||||
| YoY Change | -100.0% | -54.54% | -35.29% | -26.09% | -20.7% | -43.37% | -100.0% | 1156.67% | 76.47% | -83.65% | 1385.71% | -22.22% | -18.18% | -85.9% | -1.27% | 6.76% | 2.78% | 7.46% | 0.0% | 6600.0% | 0.0% | ||||||||
| Total Long-Term Assets | $0.00 | $0.00 | $0.00 | $24.41K | $53.70K | $82.99K | $112.3K | $141.6K | $250.0K | $0.00 | $0.00 | $0.00 | $0.00 | $3.780M | $5.960M | $6.520M | $11.80M | $6.200M | $6.860M | $6.860M | $6.420M | $6.980M | $7.530M | $7.880M | $7.690M | $7.930M | $1.440M | $250.0K | $110.0K |
| YoY Change | -100.0% | -54.54% | -35.29% | -26.09% | -20.7% | -43.37% | -100.0% | -36.58% | -8.59% | -44.75% | 90.32% | -9.62% | 0.0% | 6.85% | -8.02% | -7.3% | -4.44% | 2.47% | -3.03% | 450.69% | 476.0% | 127.27% | |||||||
| Total Assets | $8.949M | $11.98M | $58.78K | $131.8K | $900.0K | $1.233M | $768.1K | $7.338M | $885.9K | $463.0K | $10.00K | $940.0K | $1.380M | $6.150M | $7.290M | $8.370M | $20.04M | $9.500M | $11.14M | $11.00M | $7.580M | $7.820M | $8.350M | $10.35M | $8.250M | $10.40M | $7.930M | $630.0K | $190.0K |
| YoY Change | |||||||||||||||||||||||||||||
| Accounts Payable | $33.73K | $145.2K | $279.8K | $269.4K | $315.9K | $384.8K | $535.0K | $297.8K | $383.4K | $325.0K | $290.0K | $370.0K | $370.0K | $530.0K | $1.110M | $1.120M | $2.140M | $310.0K | $410.0K | $380.0K | $240.0K | $490.0K | $500.0K | $550.0K | $480.0K | $800.0K | $280.0K | $50.00K | $30.00K |
| YoY Change | -76.76% | -48.13% | 3.87% | -14.72% | -17.9% | -28.06% | 79.62% | -22.31% | 17.97% | 12.06% | -21.62% | 0.0% | -30.19% | -52.25% | -0.89% | -47.66% | 590.32% | -24.39% | 7.89% | 58.33% | -51.02% | -2.0% | -9.09% | 14.58% | -40.0% | 185.71% | 460.0% | 66.67% | |
| Accrued Expenses | $631.4K | $122.6K | $14.97K | $0.00 | $0.00 | $190.0K | $170.0K | $460.0K | $670.0K | $520.0K | $360.0K | $40.00K | $140.0K | $10.00K | $220.0K | $230.0K | |||||||||||||
| YoY Change | 414.95% | 719.1% | -100.0% | 11.76% | -63.04% | -31.34% | 28.85% | 44.44% | 800.0% | -71.43% | 1300.0% | -95.45% | -4.35% | ||||||||||||||||
| Deferred Revenue | |||||||||||||||||||||||||||||
| YoY Change | |||||||||||||||||||||||||||||
| Short-Term Debt | $0.00 | $411.0K | $231.0K | $30.04K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $70.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $20.00K | $80.00K | $140.0K | $480.0K | $250.0K | $320.0K | $0.00 | $0.00 |
| YoY Change | -100.0% | 77.92% | 668.97% | -100.0% | -100.0% | -75.0% | -42.86% | -70.83% | 92.0% | -21.88% | |||||||||||||||||||
| Long-Term Debt Due | $1.330M | $1.980M | $5.210M | $2.660M | $230.0K | $510.0K | $410.0K | $100.0K | $160.0K | $190.0K | $210.0K | $30.00K | $40.00K | $50.00K | |||||||||||||||
| YoY Change | -32.83% | -62.0% | 95.86% | 1056.52% | -54.9% | 24.39% | 310.0% | -37.5% | -15.79% | -9.52% | -25.0% | -20.0% | |||||||||||||||||
| Total Short-Term Liabilities | $665.2K | $678.8K | $679.6K | $425.4K | $431.1K | $700.7K | $601.5K | $308.1K | $461.9K | $400.9K | $780.0K | $560.0K | $540.0K | $3.440M | $3.980M | $7.100M | $6.860M | $590.0K | $1.120M | $960.0K | $580.0K | $750.0K | $800.0K | $920.0K | $970.0K | $1.120M | $630.0K | $290.0K | $80.00K |
| YoY Change | -2.01% | -0.13% | 59.76% | -1.32% | -38.47% | 16.49% | 95.21% | -33.29% | 15.21% | -48.6% | 39.29% | 3.7% | -84.3% | -13.57% | -43.94% | 3.5% | 1062.71% | -47.32% | 16.67% | 65.52% | -22.67% | -6.25% | -13.04% | -5.15% | -13.39% | 77.78% | 117.24% | 262.5% | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $66.56K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $670.0K | $2.160M | $2.450M | $0.00 | $3.240M | $3.790M | $4.010M | $4.080M | $3.630M | $3.730M | $3.890M | $4.080M | $4.000M | $4.000M | $0.00 | $190.0K | $40.00K |
| YoY Change | -100.0% | -100.0% | -68.98% | -11.84% | -100.0% | -14.51% | -5.49% | -1.72% | 12.4% | -2.68% | -4.11% | -4.66% | 2.0% | 0.0% | -100.0% | 375.0% | |||||||||||||
| Other Long-Term Liabilities | $3.000M | $3.000M | $3.000M | $3.000M | $3.000M | $500.0K | $0.00 | $0.00 | $510.0K | $540.0K | $140.0K | $140.0K | $0.00 | ||||||||||||||||
| YoY Change | 0.0% | 0.0% | 0.0% | 0.0% | 500.0% | -100.0% | -5.56% | 285.71% | 0.0% | ||||||||||||||||||||
| Total Long-Term Liabilities | $3.000M | $3.000M | $3.000M | $3.067M | $3.000M | $500.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $510.0K | $1.210M | $2.300M | $2.590M | $0.00 | $3.240M | $3.790M | $4.010M | $4.080M | $3.630M | $3.730M | $3.890M | $4.080M | $4.000M | $4.000M | $0.00 | $190.0K | $40.00K |
| YoY Change | 0.0% | 0.0% | -2.17% | 2.22% | 500.0% | -100.0% | -57.85% | -47.39% | -11.2% | -100.0% | -14.51% | -5.49% | -1.72% | 12.4% | -2.68% | -4.11% | -4.66% | 2.0% | 0.0% | -100.0% | 375.0% | ||||||||
| Total Liabilities | $3.665M | $3.679M | $3.680M | $3.492M | $3.431M | $1.201M | $601.5K | $308.1K | $461.9K | $400.9K | $780.0K | $1.070M | $1.750M | $5.750M | $6.580M | $7.110M | $10.11M | $4.370M | $5.130M | $5.040M | $4.210M | $4.480M | $4.690M | $4.990M | $4.970M | $5.120M | $630.0K | $470.0K | $120.0K |
| YoY Change | -0.37% | -0.02% | 5.37% | 1.77% | 185.77% | 99.61% | 95.21% | -33.29% | 15.21% | -48.6% | -27.1% | -38.86% | -69.57% | -12.61% | -7.45% | -29.67% | 131.35% | -14.81% | 1.79% | 19.71% | -6.03% | -4.48% | -6.01% | 0.4% | -2.93% | 712.7% | 34.04% | 291.67% |
Ownership
Basic Shares Outstanding
Loading...
Loading...
Diluted Shares Outstanding
Loading...
Loading...
Preferred Stock
Loading...
Loading...
Treasury Stock Shares
Loading...
Loading...
Stock Issuance & Repurchase
Loading...
Loading...
Ownership Data
| Concept | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Basic Shares Outstanding | 172.0M shares | 366.2M shares | 376.2M shares | 17.94M shares | 13.65M shares | ||||||||||||||||||||||||
| Diluted Shares Outstanding | 172.0M shares | 367.8M shares | 376.2M shares | 17.94M shares | 13.65M shares | ||||||||||||||||||||||||
| Preferred Stock | |||||||||||||||||||||||||||||
| Treasury Stock Shares |
Return On Shareholders' Equity
Loading...
Loading...
Book Value
Loading...
Loading...
Free Cash Flow
Loading...
Loading...
Free Cash Flow YoY
Loading...
Loading...
Free Cash Flow Margin
Loading...
Loading...
Dividends
Dividends
Loading...
Loading...
Stock Price
Loading...
Market Cap: $11.373 Million
About Inhibitor Therapeutics, Inc.
Inhibitor Therapeutics, Inc. engages in the discovery, development, and commercialization of therapeutics for patients with cancer. The company is headquartered in Tampa, Florida and currently employs 3 full-time employees. The firm is focused on developing and commercializing therapeutics based on already approved active pharmaceuticals that have patent-protected methods of use and/or methods of delivery for patients with certain cancers and certain non-cancerous proliferation disorders. Its primary focus is on the development of therapies initially for basal cell carcinoma (BCC), prostate and lung cancers in the United States utilizing itraconazole, a drug approved by the United States Food and Drug Administration (FDA) to treat fungal infections. The firm has developed intellectual property and know-how related to the treatment of cancer patients using itraconazole. The firm's intellectual property in the form of issued United States patents includes treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitors, and treatment of lung cancer using hedgehog pathway inhibitors.
Industry: Pharmaceutical Preparations Peers: Aileron Therapeutics, Inc. APPLIED GENETIC TECHNOLOGIES CORP Indaptus Therapeutics, Inc. Metacrine, Inc. Tempest Therapeutics, Inc. NANOVIRICIDES, INC. OPGEN INC ORGANOVO HOLDINGS, INC.
